Anesiva

From WikiCover

Anesiva is a late-stage biopharmaceutical company that seeks to be the leader in the development and commercialization of novel therapeutic treatments for pain. The company has one FDA-approved product, Zingo, for the reduction of pain associated with peripheral venous access procedures in children three to eighteen years of age. The second product in Anesiva's portfolio, Adlea (formerly 4975), has been shown to reduce pain after only a single administration for weeks to months in multiple settings in numerous mid-stage clinical trials for site-specific, acute and chronic, moderate-to-severe pain.

Headquarters: South San Francisco, California

Website: http://www.anesiva.com/